Publication | Closed Access

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy

Chronic Inflammatory DiseasesDysbiosisAutoimmune DiseaseMucosal ImmunologyCheckpoint Blockade TherapyImmunologyGut MicrobiologyOlder IndividualsAutoimmunityGut BarrierIntestinal MicrobiotaMicrobiomeImmunotherapyMedicineHost-microbe InteractionSpecific Enterotype